4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-062374
Director gave up 12,639 shares (to pay taxes)
- Director acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRENNAN MURRAY Director | 2017-11-20 | Option exercise | +20,000 | $2.73 | $54,600 | 74,814 | D |
| BRENNAN MURRAY Director | 2017-11-20 | Shares withheld for taxes | −12,639 | $4.32 | $54,600 | 62,175 | D |
| Derivatives | |||||||
| BRENNAN MURRAY Director | 2017-11-20 | Option exercise · Stock Option (right to buy) | −20,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…